200 related articles for article (PubMed ID: 31056361)
21. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
22. Serum ferritin is a biomarker for liver mortality in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Barton JC; Guo H; Alter D; Speechley M
Ann Hepatol; 2015; 14(3):348-53. PubMed ID: 25864215
[TBL] [Abstract][Full Text] [Related]
23. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
[TBL] [Abstract][Full Text] [Related]
24. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
25. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
McLaren GD; McLaren CE; Adams PC; Barton JC; Reboussin DM; Gordeuk VR; Acton RT; Harris EL; Speechley MR; Sholinsky P; Dawkins FW; Snively BM; Vogt TM; Eckfeldt JH;
Can J Gastroenterol; 2008 Nov; 22(11):923-30. PubMed ID: 19018338
[TBL] [Abstract][Full Text] [Related]
26. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
Lim A; Speechley M; Adams PC
Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357
[TBL] [Abstract][Full Text] [Related]
27. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
28. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
31. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
[TBL] [Abstract][Full Text] [Related]
32. Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.
Barton JC; Barton JC; Patel N; McLaren GD
PLoS One; 2021; 16(12):e0261690. PubMed ID: 34932603
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.
Waalen J; Felitti V; Gelbart T; Ho NJ; Beutler E
Mayo Clin Proc; 2002 Jun; 77(6):522-30. PubMed ID: 12059121
[TBL] [Abstract][Full Text] [Related]
34.
Sandnes M; Vorland M; Ulvik RJ; Reikvam H
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440336
[No Abstract] [Full Text] [Related]
35. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
O'Toole R; Romeril K; Bromhead C
Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression.
Distante S; Berg JP; Lande K; Haug E; Bell H
Scand J Gastroenterol; 1999 May; 34(5):529-34. PubMed ID: 10423072
[TBL] [Abstract][Full Text] [Related]
37. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
38. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
39. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy.
Cassanelli S; Pignatti E; Montosi G; Garuti C; Mariano M; Campioli D; Carbonieri A; Baldini E; Pietrangelo A
J Hepatol; 2001 Apr; 34(4):523-8. PubMed ID: 11394651
[TBL] [Abstract][Full Text] [Related]
40. Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.
Secondes ES; Wallace DF; Rishi G; McLaren GD; McLaren CE; Chen WP; Ramm LE; Powell LW; Ramm GA; Barton JC; Subramaniam VN
Blood Cells Mol Dis; 2020 Nov; 85():102463. PubMed ID: 32652459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
